EGFR and brain neoplasm: Because of variable treatment among these histological brain tumor groups, further analyses must include large cohorts of standardized treatment arms and measurements of other genetic features such as MGMT status, EGFR wildtype amplification, and the presence of EGFRvIII to confirm the validity of our findings.